Delivery Order SPE2DR25D9114-SPE2DR26FMDV1
- Not listed
- The Defense Logistics Agency awarded a $10,588.89 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count units). The delivery order, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,373.61 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nuplazid 10 mg tablets (30-count packages). The award, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, carries a firm fixed-price contract type with no set-aside designation, indicating the vendor competed in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc. on August 26, 2025, for the supply of Nuplazid 34 mg capsules in quantities of 30. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a continuation of the ongoing pharmaceutical supply relationship between DLA and the Park Ridge, Illinois-based vendor. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count units). The award, issued on June 2, 2025, with an ultimate completion date of June 24, 2025, carries no set-aside designation. This delivery order represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $20,751.06 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of NUPLAZID 34 mg capsules (30-count packaging). This firm fixed-price delivery order, issued on October 23, 2025, with an ultimate completion date of November 14, 2025, carries no set-aside designation, indicating the award was made through open competition. The delivery order was...
- The Defense Logistics Agency issued a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules in 30-count packaging. This delivery order was awarded on September 8, 2025, with an ultimate completion date of September 29, 2025, utilizing firm fixed-price pricing with no set-aside designation. The order represents a discrete fulfillment under DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 20, 2025. The contract covers the supply of Nuplazid 34 mg capsules in quantities of 30, with a firm fixed-price structure and an ultimate completion date of September 11, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete on an...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on September 29, 2025, for the supply of Nuplazid (pimavanserin) 34 mg capsules in quantities of 30 units. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this delivery order under a firm fixed-price contract with a ceiling value of $10,375.53. The order represents no set-aside designation and carries an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc. for the supply of Nuplazid 34 mg capsules (30-count units) with an ultimate completion date of September 26, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its primary location. This delivery order is issued...
- The Defense Logistics Agency awarded a $3,458.51 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on June 16, 2025, for the supply of Nuplazid 34 mg capsules (30-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge facility with an ultimate completion date of July 9, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to...
- SPE2DR25D9114Indefinite Delivery Contract
- SPE2DR25D9114-SPE2DR26FMDV1Delivery Order
The Defense Logistics Agency awarded a $21,177.78 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules in quantities of 30. The delivery order, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group was selected as the awardee based on its established capabilities and performance record within the Defense Logistics Agency's pharmaceutical supply chain. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling value through December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying a comprehensive range of pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables to support Department of Defense healthcare operations globally. The current delivery order for Nuplazid reflects the routine pharmaceutical fulfillment activity authorized under this broader strategic contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.2k | 10/31/25 |